Cassandra Pardini, PharmD

Most Recent Articles by Cassandra Pardini, PharmD

Antidepressant Tx May Also Improve Asthma Symptoms in Comorbid Patients

By Mar 21, 2018

The authors reported that ACQ scores (P=0.04) and oral corticosteroid use (P=0.04) were significantly reduced in high severity completers (n=21) receiving escitalopram.

<i>DSM-5</i>-Defined Major Depressive Disorder Highly Prevalent Among U.S. Adults

By Mar 21, 2018

To determine the prevalence of DSM-5 MDD as well as DSM-5 specifiers, the study authors conducted "in-person interviews with a representative sample of US noninstitutionalized civilian adults (≥18 years) (n = 36 309) who participated in the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions III (NESARC-III)."

Predictors of Relapse Identified in Youth With Major Depressive Disorder

By Mar 20, 2018

Relapse was defined as a total score of ≥40 according to the Children's Depression Rating Scale-Revised in addition to worsening of depressive symptoms for ≥2 weeks.

Antipsychotic Prescribing for MDD Patients: Recent Trends Examined

By Mar 19, 2018

Aripiprazole, olanzapine, quetiapine, and risperidone were reported as the most commonly prescribed antipsychotic medications.

Peripheral Neuropathy Management: A Guide for Primary Care Clinicians

By Mar 14, 2018

Peripheral neuropathy is tied to significant morbidity and decrease in quality of life, therefore it is imperative to efficiently diagnosis.

More Articles by Cassandra Pardini, PharmD